The U.S. Food and Drug Administration on Monday gave full approval to Moderna Inc's ( MKRNA.O) COVID-19 vaccine for people age 18 and older, making it the second fully approved vaccine for the virus, according to Reuters.
The Moderna vaccine has been authorized for emergency use in the United States since December 2020